Clinical Mass Spectrometry Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type ( Gas chromatography Mass Spectrometry, Liquid chromatography Mass Spectrometry, MALDI-TOF Mass Spectrometer, Capillary Electrophoresis Mass Spectrometry, Ion Mobility Spectrometry ); Application ( Drug Discovery, Clinical Testing, Proteomics, Others ); End User ( Hospitals, Diagnostic Centers, Research Laboratories, Others )

Report Code: TIPBT00002551 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW

Clinical mass spectrometry is a qualitative and quantitative analytical tool used tevaluate complex mixtures during the drug development process, including defining the lead compound and its conformational information. Clinical diagnostic mass spectrometers are capable texamine a limited range of samples such as proteins, biomarkers, or drug molecules at once, even in cases of low concentrations thus, making them an important tool for diagnostic medical laboratories.

MARKET SCOPE

The "Global Clinical Mass Spectrometry Market Analysis t2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims tprovide an overview of the clinical mass spectrometry market with detailed market segmentation by product type, application, end user, and geography. The report provides key statistics on the market status of the leading clinical mass spectrometry market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  • Based on product type, the global clinical mass spectrometry market is segmented intgas chromatography-mass spectrometry, liquid chromatography-mass spectrometry, MALDI TOF mass spectrometer, capillary electrophoresis-mass spectrometry, and ion mobility spectrometry.
  • On the basis of application, the market is segmented intdrug discovery, clinical testing, proteomics and others.
  • Based on end user, the market is bifurcated inthospitals, diagnostic centers, and research laboratories and others.

MARKET DYNAMICS

Drivers

  • Advancements in technology of spectrometry
  • Increased investments in R&D and advancement of healthcare technologies
  • Increase in developments in the emerging nations
  • Funds provided by the government bodies

Restraints

  • The capital investment needed for installation and maintenance of these devices

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It alsprovides market size and forecast estimates from the year 2019 t2028 with respect tfive major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The clinical mass spectrometry market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report alsprovides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the clinical mass spectrometry market in these regions.

IMPACT OF COVID-19 ON CLINICAL MASS SPECTROMETRY MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due tlockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition tthis, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities. Clinical mass spectrometry (MS) can provide useful diagnostic information that complements genomic data, allowing researchers tlearn more about the COVID-19 disease caused by the SARS-CoV-2 virus.

KEY MARKET PLAYERS

The report covers key developments in the clinical mass spectrometry market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from clinical mass spectrometry market are anticipated tlucrative growth opportunities in the future with the rising demand for clinical mass spectrometry in the global market.

The report alsincludes the profiles of key companies along with their SWOT analysis and market strategies in the clinical mass spectrometry market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • Bruker
  • ThermFisher Scientific Inc.
  • Danaher
  • Agilent Technologies
  • PerkinElmer Inc.
  • Shimadzu Corporation
  • Kore Technologies
  • BME Bergmann
  • Mass Spectrometry Instruments
  • Photonics GmbH

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

 

 

TABLE OF CONTENTS

1. INTRODUCTION
 1.1. SCOPE OF THE STUDY
 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
 1.3. MARKET SEGMENTATION
 1.3.1 Clinical Mass Spectrometry Market - By Product Type
 1.3.2 Clinical Mass Spectrometry Market - By Application
 1.3.3 Clinical Mass Spectrometry Market - By End User
 1.3.4 Clinical Mass Spectrometry Market - By Region
 1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CLINICAL MASS SPECTROMETRY MARKET LANDSCAPE
 4.1. OVERVIEW
 4.2. PEST ANALYSIS
 4.2.1 North America - Pest Analysis
 4.2.2 Europe - Pest Analysis
 4.2.3 Asia-Pacific - Pest Analysis
 4.2.4 Middle East and Africa - Pest Analysis
 4.2.5 South and Central America - Pest Analysis
 4.3. EXPERT OPINIONS
5. CLINICAL MASS SPECTROMETRY MARKET - KEY MARKET DYNAMICS
 5.1. KEY MARKET DRIVERS
 5.2. KEY MARKET RESTRAINTS
 5.3. KEY MARKET OPPORTUNITIES
 5.4. FUTURE TRENDS
 5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CLINICAL MASS SPECTROMETRY MARKET - GLOBAL MARKET ANALYSIS
 6.1. CLINICAL MASS SPECTROMETRY - GLOBAL MARKET OVERVIEW
 6.2. CLINICAL MASS SPECTROMETRY - GLOBAL MARKET AND FORECAST TO 2028
 6.3. MARKET POSITIONING
7. CLINICAL MASS SPECTROMETRY MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
 7.1. OVERVIEW
 7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
 7.3. GAS CHROMATOGRAPHY MASS SPECTROMETRY
 7.3.1. Overview
 7.3.2. Gas chromatography Mass Spectrometry Market Forecast and Analysis
 7.4. LIQUID CHROMATOGRAPHY MASS SPECTROMETRY
 7.4.1. Overview
 7.4.2. Liquid chromatography Mass Spectrometry Market Forecast and Analysis
 7.5. MALDI-TOF MASS SPECTROMETER
 7.5.1. Overview
 7.5.2. MALDI-TOF Mass Spectrometer Market Forecast and Analysis
 7.6. CAPILLARY ELECTROPHORESIS MASS SPECTROMETRY
 7.6.1. Overview
 7.6.2. Capillary Electrophoresis Mass Spectrometry Market Forecast and Analysis
 7.7. ION MOBILITY SPECTROMETRY
 7.7.1. Overview
 7.7.2. Ion Mobility Spectrometry Market Forecast and Analysis
8. CLINICAL MASS SPECTROMETRY MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
 8.1. OVERVIEW
 8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
 8.3. DRUG DISCOVERY
 8.3.1. Overview
 8.3.2. Drug Discovery Market Forecast and Analysis
 8.4. CLINICAL TESTING
 8.4.1. Overview
 8.4.2. Clinical Testing Market Forecast and Analysis
 8.5. PROTEOMICS
 8.5.1. Overview
 8.5.2. Proteomics Market Forecast and Analysis
 8.6. OTHERS
 8.6.1. Overview
 8.6.2. Others Market Forecast and Analysis
9. CLINICAL MASS SPECTROMETRY MARKET - REVENUE AND FORECASTS TO 2028 - END USER
 9.1. OVERVIEW
 9.2. END USER MARKET FORECASTS AND ANALYSIS
 9.3. HOSPITALS
 9.3.1. Overview
 9.3.2. Hospitals Market Forecast and Analysis
 9.4. DIAGNOSTIC CENTERS
 9.4.1. Overview
 9.4.2. Diagnostic Centers Market Forecast and Analysis
 9.5. RESEARCH LABORATORIES
 9.5.1. Overview
 9.5.2. Research Laboratories Market Forecast and Analysis
 9.6. OTHERS
 9.6.1. Overview
 9.6.2. Others Market Forecast and Analysis
10. CLINICAL MASS SPECTROMETRY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
 10.1. NORTH AMERICA
 10.1.1 North America Clinical Mass Spectrometry Market Overview
 10.1.2 North America Clinical Mass Spectrometry Market Forecasts and Analysis
 10.1.3 North America Clinical Mass Spectrometry Market Forecasts and Analysis - By Product Type
 10.1.4 North America Clinical Mass Spectrometry Market Forecasts and Analysis - By Application
 10.1.5 North America Clinical Mass Spectrometry Market Forecasts and Analysis - By End User
 10.1.6 North America Clinical Mass Spectrometry Market Forecasts and Analysis - By Countries
 10.1.6.1 United States Clinical Mass Spectrometry Market
 10.1.6.1.1 United States Clinical Mass Spectrometry Market by Product Type
 10.1.6.1.2 United States Clinical Mass Spectrometry Market by Application
 10.1.6.1.3 United States Clinical Mass Spectrometry Market by End User
 10.1.6.2 Canada Clinical Mass Spectrometry Market
 10.1.6.2.1 Canada Clinical Mass Spectrometry Market by Product Type
 10.1.6.2.2 Canada Clinical Mass Spectrometry Market by Application
 10.1.6.2.3 Canada Clinical Mass Spectrometry Market by End User
 10.1.6.3 Mexico Clinical Mass Spectrometry Market
 10.1.6.3.1 Mexico Clinical Mass Spectrometry Market by Product Type
 10.1.6.3.2 Mexico Clinical Mass Spectrometry Market by Application
 10.1.6.3.3 Mexico Clinical Mass Spectrometry Market by End User
 10.2. EUROPE
 10.2.1 Europe Clinical Mass Spectrometry Market Overview
 10.2.2 Europe Clinical Mass Spectrometry Market Forecasts and Analysis
 10.2.3 Europe Clinical Mass Spectrometry Market Forecasts and Analysis - By Product Type
 10.2.4 Europe Clinical Mass Spectrometry Market Forecasts and Analysis - By Application
 10.2.5 Europe Clinical Mass Spectrometry Market Forecasts and Analysis - By End User
 10.2.6 Europe Clinical Mass Spectrometry Market Forecasts and Analysis - By Countries
 10.2.6.1 Germany Clinical Mass Spectrometry Market
 10.2.6.1.1 Germany Clinical Mass Spectrometry Market by Product Type
 10.2.6.1.2 Germany Clinical Mass Spectrometry Market by Application
 10.2.6.1.3 Germany Clinical Mass Spectrometry Market by End User
 10.2.6.2 France Clinical Mass Spectrometry Market
 10.2.6.2.1 France Clinical Mass Spectrometry Market by Product Type
 10.2.6.2.2 France Clinical Mass Spectrometry Market by Application
 10.2.6.2.3 France Clinical Mass Spectrometry Market by End User
 10.2.6.3 Italy Clinical Mass Spectrometry Market
 10.2.6.3.1 Italy Clinical Mass Spectrometry Market by Product Type
 10.2.6.3.2 Italy Clinical Mass Spectrometry Market by Application
 10.2.6.3.3 Italy Clinical Mass Spectrometry Market by End User
 10.2.6.4 Spain Clinical Mass Spectrometry Market
 10.2.6.4.1 Spain Clinical Mass Spectrometry Market by Product Type
 10.2.6.4.2 Spain Clinical Mass Spectrometry Market by Application
 10.2.6.4.3 Spain Clinical Mass Spectrometry Market by End User
 10.2.6.5 United Kingdom Clinical Mass Spectrometry Market
 10.2.6.5.1 United Kingdom Clinical Mass Spectrometry Market by Product Type
 10.2.6.5.2 United Kingdom Clinical Mass Spectrometry Market by Application
 10.2.6.5.3 United Kingdom Clinical Mass Spectrometry Market by End User
 10.2.6.6 Rest of Europe Clinical Mass Spectrometry Market
 10.2.6.6.1 Rest of Europe Clinical Mass Spectrometry Market by Product Type
 10.2.6.6.2 Rest of Europe Clinical Mass Spectrometry Market by Application
 10.2.6.6.3 Rest of Europe Clinical Mass Spectrometry Market by End User
 10.3. ASIA-PACIFIC
 10.3.1 Asia-Pacific Clinical Mass Spectrometry Market Overview
 10.3.2 Asia-Pacific Clinical Mass Spectrometry Market Forecasts and Analysis
 10.3.3 Asia-Pacific Clinical Mass Spectrometry Market Forecasts and Analysis - By Product Type
 10.3.4 Asia-Pacific Clinical Mass Spectrometry Market Forecasts and Analysis - By Application
 10.3.5 Asia-Pacific Clinical Mass Spectrometry Market Forecasts and Analysis - By End User
 10.3.6 Asia-Pacific Clinical Mass Spectrometry Market Forecasts and Analysis - By Countries
 10.3.6.1 Australia Clinical Mass Spectrometry Market
 10.3.6.1.1 Australia Clinical Mass Spectrometry Market by Product Type
 10.3.6.1.2 Australia Clinical Mass Spectrometry Market by Application
 10.3.6.1.3 Australia Clinical Mass Spectrometry Market by End User
 10.3.6.2 China Clinical Mass Spectrometry Market
 10.3.6.2.1 China Clinical Mass Spectrometry Market by Product Type
 10.3.6.2.2 China Clinical Mass Spectrometry Market by Application
 10.3.6.2.3 China Clinical Mass Spectrometry Market by End User
 10.3.6.3 India Clinical Mass Spectrometry Market
 10.3.6.3.1 India Clinical Mass Spectrometry Market by Product Type
 10.3.6.3.2 India Clinical Mass Spectrometry Market by Application
 10.3.6.3.3 India Clinical Mass Spectrometry Market by End User
 10.3.6.4 Japan Clinical Mass Spectrometry Market
 10.3.6.4.1 Japan Clinical Mass Spectrometry Market by Product Type
 10.3.6.4.2 Japan Clinical Mass Spectrometry Market by Application
 10.3.6.4.3 Japan Clinical Mass Spectrometry Market by End User
 10.3.6.5 South Korea Clinical Mass Spectrometry Market
 10.3.6.5.1 South Korea Clinical Mass Spectrometry Market by Product Type
 10.3.6.5.2 South Korea Clinical Mass Spectrometry Market by Application
 10.3.6.5.3 South Korea Clinical Mass Spectrometry Market by End User
 10.3.6.6 Rest of Asia-Pacific Clinical Mass Spectrometry Market
 10.3.6.6.1 Rest of Asia-Pacific Clinical Mass Spectrometry Market by Product Type
 10.3.6.6.2 Rest of Asia-Pacific Clinical Mass Spectrometry Market by Application
 10.3.6.6.3 Rest of Asia-Pacific Clinical Mass Spectrometry Market by End User
 10.4. MIDDLE EAST AND AFRICA
 10.4.1 Middle East and Africa Clinical Mass Spectrometry Market Overview
 10.4.2 Middle East and Africa Clinical Mass Spectrometry Market Forecasts and Analysis
 10.4.3 Middle East and Africa Clinical Mass Spectrometry Market Forecasts and Analysis - By Product Type
 10.4.4 Middle East and Africa Clinical Mass Spectrometry Market Forecasts and Analysis - By Application
 10.4.5 Middle East and Africa Clinical Mass Spectrometry Market Forecasts and Analysis - By End User
 10.4.6 Middle East and Africa Clinical Mass Spectrometry Market Forecasts and Analysis - By Countries
 10.4.6.1 South Africa Clinical Mass Spectrometry Market
 10.4.6.1.1 South Africa Clinical Mass Spectrometry Market by Product Type
 10.4.6.1.2 South Africa Clinical Mass Spectrometry Market by Application
 10.4.6.1.3 South Africa Clinical Mass Spectrometry Market by End User
 10.4.6.2 Saudi Arabia Clinical Mass Spectrometry Market
 10.4.6.2.1 Saudi Arabia Clinical Mass Spectrometry Market by Product Type
 10.4.6.2.2 Saudi Arabia Clinical Mass Spectrometry Market by Application
 10.4.6.2.3 Saudi Arabia Clinical Mass Spectrometry Market by End User
 10.4.6.3 U.A.E Clinical Mass Spectrometry Market
 10.4.6.3.1 U.A.E Clinical Mass Spectrometry Market by Product Type
 10.4.6.3.2 U.A.E Clinical Mass Spectrometry Market by Application
 10.4.6.3.3 U.A.E Clinical Mass Spectrometry Market by End User
 10.4.6.4 Rest of Middle East and Africa Clinical Mass Spectrometry Market
 10.4.6.4.1 Rest of Middle East and Africa Clinical Mass Spectrometry Market by Product Type
 10.4.6.4.2 Rest of Middle East and Africa Clinical Mass Spectrometry Market by Application
 10.4.6.4.3 Rest of Middle East and Africa Clinical Mass Spectrometry Market by End User
 10.5. SOUTH AND CENTRAL AMERICA
 10.5.1 South and Central America Clinical Mass Spectrometry Market Overview
 10.5.2 South and Central America Clinical Mass Spectrometry Market Forecasts and Analysis
 10.5.3 South and Central America Clinical Mass Spectrometry Market Forecasts and Analysis - By Product Type
 10.5.4 South and Central America Clinical Mass Spectrometry Market Forecasts and Analysis - By Application
 10.5.5 South and Central America Clinical Mass Spectrometry Market Forecasts and Analysis - By End User
 10.5.6 South and Central America Clinical Mass Spectrometry Market Forecasts and Analysis - By Countries
 10.5.6.1 Brazil Clinical Mass Spectrometry Market
 10.5.6.1.1 Brazil Clinical Mass Spectrometry Market by Product Type
 10.5.6.1.2 Brazil Clinical Mass Spectrometry Market by Application
 10.5.6.1.3 Brazil Clinical Mass Spectrometry Market by End User
 10.5.6.2 Argentina Clinical Mass Spectrometry Market
 10.5.6.2.1 Argentina Clinical Mass Spectrometry Market by Product Type
 10.5.6.2.2 Argentina Clinical Mass Spectrometry Market by Application
 10.5.6.2.3 Argentina Clinical Mass Spectrometry Market by End User
 10.5.6.3 Rest of South and Central America Clinical Mass Spectrometry Market
 10.5.6.3.1 Rest of South and Central America Clinical Mass Spectrometry Market by Product Type
 10.5.6.3.2 Rest of South and Central America Clinical Mass Spectrometry Market by Application
 10.5.6.3.3 Rest of South and Central America Clinical Mass Spectrometry Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CLINICAL MASS SPECTROMETRY MARKET
 11.1 North America
 11.2 Europe
 11.3 Asia-Pacific
 11.4 Middle East and Africa
 11.5 South and Central America
12. INDUSTRY LANDSCAPE
 12.1. MERGERS AND ACQUISITIONS
 12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
 12.3. NEW PRODUCT LAUNCHES
 12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. CLINICAL MASS SPECTROMETRY MARKET, KEY COMPANY PROFILES
 13.1. BRUKER
 13.1.1. Key Facts
 13.1.2. Business Description
 13.1.3. Products and Services
 13.1.4. Financial Overview
 13.1.5. SWOT Analysis
 13.1.6. Key Developments
 13.2. THERMO FISHER SCIENTIFIC
 13.2.1. Key Facts
 13.2.2. Business Description
 13.2.3. Products and Services
 13.2.4. Financial Overview
 13.2.5. SWOT Analysis
 13.2.6. Key Developments
 13.3. DANAHER
 13.3.1. Key Facts
 13.3.2. Business Description
 13.3.3. Products and Services
 13.3.4. Financial Overview
 13.3.5. SWOT Analysis
 13.3.6. Key Developments
 13.4. AGILENT TECHNOLOGIES, INC
 13.4.1. Key Facts
 13.4.2. Business Description
 13.4.3. Products and Services
 13.4.4. Financial Overview
 13.4.5. SWOT Analysis
 13.4.6. Key Developments
 13.5. PERKINELMER INC.
 13.5.1. Key Facts
 13.5.2. Business Description
 13.5.3. Products and Services
 13.5.4. Financial Overview
 13.5.5. SWOT Analysis
 13.5.6. Key Developments
 13.6. SHIMADZU CORPORATION
 13.6.1. Key Facts
 13.6.2. Business Description
 13.6.3. Products and Services
 13.6.4. Financial Overview
 13.6.5. SWOT Analysis
 13.6.6. Key Developments
 13.7. KORE TECHNOLOGY
 13.7.1. Key Facts
 13.7.2. Business Description
 13.7.3. Products and Services
 13.7.4. Financial Overview
 13.7.5. SWOT Analysis
 13.7.6. Key Developments
 13.8. BERGMANN MESSGERAETE ENTWICKLUNG KG
 13.8.1. Key Facts
 13.8.2. Business Description
 13.8.3. Products and Services
 13.8.4. Financial Overview
 13.8.5. SWOT Analysis
 13.8.6. Key Developments
 13.9. WATERS CORPORATION
 13.9.1. Key Facts
 13.9.2. Business Description
 13.9.3. Products and Services
 13.9.4. Financial Overview
 13.9.5. SWOT Analysis
 13.9.6. Key Developments
 13.10. ANALYTIK JENA AG
 13.10.1. Key Facts
 13.10.2. Business Description
 13.10.3. Products and Services
 13.10.4. Financial Overview
 13.10.5. SWOT Analysis
 13.10.6. Key Developments
14. APPENDIX
 14.1. ABOUT THE INSIGHT PARTNERS
 14.2. GLOSSARY OF TERMS

The List of Companies

1.    Bruker
2.    Thermo Fisher Scientific
3.    Danaher
4.    Agilent Technologies, Inc
5.    PerkinElmer Inc.
6.    Shimadzu Corporation
7.    KORE TECHNOLOGY
8.    Bergmann Messgeraete Entwicklung KG
9.    Waters Corporation
10.    Analytik Jena AG
11.    Mass Spectrometry Instruments (MSI)
12.    Agilent Technologies Inc.
13.    Hitachi Ltd.
14.    JEOL Ltd.
15.    Waters Corp.

TIPBT00002551
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking